Curtis R. Coughlin

2.8k total citations
49 papers, 1.4k citations indexed

About

Curtis R. Coughlin is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Curtis R. Coughlin has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Clinical Biochemistry, 26 papers in Molecular Biology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Curtis R. Coughlin's work include Metabolism and Genetic Disorders (32 papers), Neonatal Health and Biochemistry (12 papers) and Mitochondrial Function and Pathology (11 papers). Curtis R. Coughlin is often cited by papers focused on Metabolism and Genetic Disorders (32 papers), Neonatal Health and Biochemistry (12 papers) and Mitochondrial Function and Pathology (11 papers). Curtis R. Coughlin collaborates with scholars based in United States, Netherlands and Canada. Curtis R. Coughlin's co-authors include Johan L.K. Van Hove, Tamim H. Shaikh, Gunter Scharer, Michael A. Swanson, Clara van Karnebeek, Marisa W. Friederich, Paige Kaplan, Can Fıçıcıoğlu, Elaine Spector and Renata C. Gallagher and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Genetics.

In The Last Decade

Curtis R. Coughlin

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Curtis R. Coughlin United States 21 774 720 310 261 255 49 1.4k
Judit García‐Villoria Spain 24 673 0.9× 511 0.7× 135 0.4× 149 0.6× 193 0.8× 73 1.3k
Chris Mühlhausen Germany 23 1.1k 1.4× 1.2k 1.7× 272 0.9× 341 1.3× 227 0.9× 43 1.8k
Tomáš Honzík Czechia 23 1.1k 1.4× 524 0.7× 225 0.7× 84 0.3× 170 0.7× 102 1.6k
Tawfeg Ben‐Omran Qatar 25 608 0.8× 334 0.5× 348 1.1× 141 0.5× 185 0.7× 62 1.4k
Annette Feigenbaum Canada 28 1.7k 2.2× 1.1k 1.6× 252 0.8× 192 0.7× 205 0.8× 61 2.3k
Ivo Barić Croatia 25 1.1k 1.4× 980 1.4× 255 0.8× 239 0.9× 223 0.9× 81 1.8k
José E. Abdenur United States 24 978 1.3× 818 1.1× 325 1.0× 134 0.5× 144 0.6× 63 1.8k
Wenjuan Qiu China 22 730 0.9× 606 0.8× 314 1.0× 81 0.3× 283 1.1× 146 1.5k
B. Merinero Spain 24 1.2k 1.6× 1.2k 1.7× 196 0.6× 219 0.8× 192 0.8× 68 1.7k
David Coman Australia 20 583 0.8× 302 0.4× 227 0.7× 79 0.3× 129 0.5× 79 1.2k

Countries citing papers authored by Curtis R. Coughlin

Since Specialization
Citations

This map shows the geographic impact of Curtis R. Coughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis R. Coughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis R. Coughlin more than expected).

Fields of papers citing papers by Curtis R. Coughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis R. Coughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis R. Coughlin. The network helps show where Curtis R. Coughlin may publish in the future.

Co-authorship network of co-authors of Curtis R. Coughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Curtis R. Coughlin. A scholar is included among the top collaborators of Curtis R. Coughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis R. Coughlin. Curtis R. Coughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karnebeek, Clara D.M. van, Valérie Gailus‐Durner, Udo F. H. Engelke, et al.. (2025). New treatment for pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: first proof-of-principle of upstream enzyme inhibition in the mouse. Brain Communications. 7(6). fcaf397–fcaf397. 1 indexed citations
2.
Woontner, Michael, José E. Abdenur, Bimal P. Chaudhari, et al.. (2024). Feasibility of newborn screening for pyridoxine-dependent epilepsy. Molecular Genetics and Metabolism. 144(1). 109002–109002. 2 indexed citations
3.
Dixon, Marjorie, Laurie Bernstein, Curtis R. Coughlin, et al.. (2024). Dietary management for pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency, a follow‐on from the international consortium guidelines. JIMD Reports. 65(3). 188–203. 1 indexed citations
4.
Footitt, Emma, Michael F. Wempe, Curtis R. Coughlin, et al.. (2024). Assessment of urinary 6‐oxo‐pipecolic acid as a biomarker for ALDH7A1 deficiency. Journal of Inherited Metabolic Disease. 48(1). e12783–e12783. 5 indexed citations
5.
Coughlin, Curtis R. & Sídney M. Gospe. (2023). Pyridoxine‐dependent epilepsy: Current perspectives and questions for future research. SHILAP Revista de lepidopterología. 1(1). 24–37. 10 indexed citations
6.
Coughlin, Curtis R., Laura A. Tseng, & Clara D. van Karnebeek. (2022). A case for newborn screening for pyridoxine-dependent epilepsy. Molecular Case Studies. 8(2). mcs.a006197–mcs.a006197. 3 indexed citations
7.
Strijker, Marin, Laura A. Tseng, Curtis R. Coughlin, et al.. (2021). Cognitive and neurological outcome of patients in the Dutch pyridoxine-dependent epilepsy (PDE-ALDH7A1) cohort, a cross-sectional study. European Journal of Paediatric Neurology. 33. 112–120. 10 indexed citations
8.
Ormond, Kelly E., Miranda L. G. Hallquist, Adam H. Buchanan, et al.. (2021). Defining the Critical Components of Informed Consent for Genetic Testing. Journal of Personalized Medicine. 11(12). 1304–1304. 18 indexed citations
9.
Hallquist, Miranda L. G., Kelly E. Ormond, Juliann M. Savatt, et al.. (2021). Application of a framework to guide genetic testing communication across clinical indications. Genome Medicine. 13(1). 71–71. 18 indexed citations
10.
Yu, Hung‐Chun, et al.. (2020). Abnormal expression of GABAA receptor sub-units and hypomotility upon loss of gabra1 in zebrafish. Biology Open. 9(4). 14 indexed citations
11.
Glover, Jacqueline J., et al.. (2020). Development and application of an ethical framework for pediatric metabolic and bariatric surgery evaluation. Surgery for Obesity and Related Diseases. 17(2). 425–433. 7 indexed citations
12.
Mostovoy, Yulia, Feyza Yilmaz, Steven Pastor, et al.. (2019). The 22q11 low copy repeats are characterized by unprecedented size and structural variability. Genome Research. 29(9). 1389–1401. 28 indexed citations
13.
Berry, Susan A., Curtis R. Coughlin, Shawn E. McCandless, et al.. (2019). Developing interactions with industry in rare diseases: lessons learned and continuing challenges. Genetics in Medicine. 22(1). 219–226. 20 indexed citations
14.
Ormond, Kelly E., Miranda L. G. Hallquist, Adam H. Buchanan, et al.. (2018). Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background. Genetics in Medicine. 21(3). 727–735. 38 indexed citations
15.
Bjoraker, Kendra, Michael A. Swanson, Curtis R. Coughlin, et al.. (2016). Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia. The Journal of Pediatrics. 170. 234–239. 47 indexed citations
16.
Wymore, Erica, et al.. (2016). Lethal neonatal hyperammonemia in severe ornithine transcarbamylase (OTC) deficiency compounded by large hepatic portosystemic shunt. Journal of Inherited Metabolic Disease. 40(1). 159–160. 1 indexed citations
17.
Coughlin, Curtis R., Michael A. Swanson, Kathryn E. Kronquist, et al.. (2016). The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT. Genetics in Medicine. 19(1). 104–111. 56 indexed citations
18.
Karnebeek, Clara van, Hans Hartmann, Sravan Jaggumantri, et al.. (2012). Lysine restricted diet for pyridoxine-dependent epilepsy: First evidence and future trials. Molecular Genetics and Metabolism. 107(3). 335–344. 80 indexed citations
19.
Coughlin, Curtis R., Gunter Scharer, & Tamim H. Shaikh. (2012). Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns. Genome Medicine. 4(10). 80–80. 42 indexed citations
20.
Coughlin, Curtis R. & Can Fıçıcıoğlu. (2010). Genotype–phenotype correlations: sudden death in an infant with very‐long‐chain acyl‐CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 33(S3). 129–131. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judit García‐Villoria Breakdown of academic impact, for papers by Chris Mühlhausen Breakdown of academic impact, for papers by Tomáš Honzík Breakdown of academic impact, for papers by Tawfeg Ben‐Omran Breakdown of academic impact, for papers by Annette Feigenbaum Breakdown of academic impact, for papers by Ivo Barić Breakdown of academic impact, for papers by José E. Abdenur Breakdown of academic impact, for papers by Wenjuan Qiu Breakdown of academic impact, for papers by B. Merinero Breakdown of academic impact, for papers by David Coman
Rankless by CCL
2026